LMR Partners’s UroGen Pharma URGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-13,746
Closed -$127K 1021
2023
Q1
$127K Buy
+13,746
New +$127K ﹤0.01% 895